House Republicans split over regulating or banning hemp THC products as the federal ban moves to Dec. 11; Trump commutes two federal marijuana sentences as DEA rescheduling advances; North Carolina legislature to take up hemp rules in November.

NEW REALM BREWING

Daily Compliance Brief

▶  Listen to today's brief (~2 min)

Vol. 1 • Edition 24 • Monday, September 7, 2026 • Alcohol & Hemp/THC Regulation • Federal + All 50 States

Good morning — here's the regulatory picture for alcohol and hemp/THC beverages, readable in about three minutes. Every headline links to the original source. A quiet holiday-weekend news cycle means a shorter run of items today.

Top Story

House Republicans split over regulating or banning hemp THC products as delayed federal ban nears

FEDERAL • Marijuana Moment • Sep 4

With the federal hemp THC recriminalization now delayed from November 12 to December 11 under the bill President Trump signed last week, House Republicans are divided on what comes next. Rep. Beth Van Duyne (R-TX) is sponsoring a bill to tax and regulate hemp THC beverages like alcohol, Rep. Morgan Griffith (R-VA) filed legislation requiring third-party testing for hemp cannabinoid products, and Rep. Dave Joyce (R-OH) proposes a commission to build an alcohol-modeled regulatory framework. Rep. Andy Harris (R-MD), who authored the ban language, rejects regulation, saying “we gotta stop poisoning children — it's that simple.” Synthetic cannabinoids remain set for recriminalization on November 12.

Why it matters: Whether hemp THC beverages get an alcohol-style regulatory pathway or a categorical federal ban is now a 14-week question — December 11 is the operative date for inventory, production, and distribution planning.

Federal

Trump commutes two federal marijuana sentences as DEA rescheduling review advances

FEDERAL • Marijuana Moment • Sep 4

President Trump commuted the sentences of two people serving federal marijuana-distribution terms, while a DEA administrative judge prepares recommendations on moving cannabis to Schedule III — a determination the DEA administrator would then finalize. Attorney General Todd Blanche reclassified state-licensed medical cannabis and FDA-approved marijuana products to Schedule III in April.

Around the States

North Carolina legislature to take up hemp product rules in November as advisory council report nears

NORTH CAROLINA • Marijuana Moment • Sep 5

North Carolina's House and Senate reconvene in November to decide hemp product regulation after splitting in July over House Bill 328, which would cap products at 0.4 mg THC and bar hemp consumable sales to those under 21. The state's Advisory Council on Cannabis, appointed by Gov. Josh Stein (D), is due to deliver regulatory recommendations by the end of 2026; the state estimates a $4 billion hemp industry employing about 16,000 residents.

Why it matters: The November session will determine whether hemp beverage sales continue under North Carolina law just as the December 11 federal deadline lands — a key watch item for Southeast distribution planning.

Florida regulators propose stricter marketing rules for medical cannabis

FLORIDA • Marijuana Moment • Sep 7

Florida regulators proposed tighter marketing restrictions for medical cannabis businesses, continuing a run of advertising rulemaking in the state's medical program.

On the Radar

Nov. 12, 2026 — Federal recriminalization of synthetic cannabinoids takes effect; this date was not moved by the one-month delay covering hemp THC products.

Dec. 11, 2026 — The delayed federal hemp THC product ban takes effect absent further congressional action; competing House bills to regulate rather than ban are pending.

DEA rescheduling — An administrative judge's recommendation on moving cannabis to Schedule III is pending, with a final determination by the DEA administrator to follow.

 

Jeremy Barnes | Chief Financial Officer, New Realm Brewing Co.

Prepared for New Realm's leadership team and valued partners. This brief is for general informational purposes only and is not legal advice; it is compiled with AI assistance from the linked sources — please confirm details at the link before acting on them.

Subscribe   Unsubscribe

Buttons not working? Reply to this email with the word subscribe or unsubscribe. Requests are processed automatically each morning before send.

Read online & browse the archive: compliance.newrealmbrewing.com • Listen & follow: Apple Podcasts • Spotify • Amazon Music • All apps

» jbarnes@newrealmbrewing.com

» newrealmbrewing.com

» Facebook | Instagram | Twitter | LinkedIn

Audio transcript (~2 min read)

This is the New Realm Compliance Brief, Volume One, Edition Twenty Four, for Monday, September Seventh.

Our top story. With the federal hemp T H C recriminalization now delayed from November twelfth to December eleventh under the bill President Trump signed last week, House Republicans are divided on what comes next. Representative Beth Van Duyne of Texas is sponsoring a bill to tax and regulate hemp T H C beverages like alcohol. Representative Morgan Griffith of Virginia filed legislation requiring third party testing for hemp cannabinoid products. And Representative Dave Joyce of Ohio proposes a commission to build a regulatory framework modeled on alcohol rules. Representative Andy Harris of Maryland, who authored the ban language, rejects regulation and said the priority is stopping sales that reach children. Synthetic cannabinoids remain set for recriminalization on November twelfth, a date the delay did not move.

In other federal news, President Trump commuted the sentences of two people serving federal marijuana distribution terms, while a D E A administrative judge prepares a recommendation on moving cannabis to Schedule Three. The D E A administrator would make the final determination.

Around the states. North Carolina's legislature reconvenes in November to decide hemp product regulation, after the two chambers split in July over a bill capping products at four tenths of a milligram of T H C and barring sales to those under twenty one. The governor's advisory council is due to deliver recommendations by the end of the year. And in Florida, regulators proposed stricter marketing rules for medical cannabis businesses.

On the radar: November twelfth for the synthetic cannabinoid recriminalization, and December eleventh for the delayed federal hemp T H C ban, absent further action from Congress.

Full details and source links are in today's email. This update is for general information only — it is not legal advice.